These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23672411)

  • 21. A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth.
    Patel Y; Shah N; Lee JS; Markoutsa E; Jie C; Liu S; Botbyl R; Reisman D; Xu P; Chen H
    Oncotarget; 2016 Apr; 7(14):18295-308. PubMed ID: 26918448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells.
    Sun X; Zhang J; Wang Z; Ji W; Tian R; Zhang F; Niu R
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
    Tang C; Luo H; Luo D; Yang H; Zhou X
    Oncol Rep; 2018 Feb; 39(2):611-618. PubMed ID: 29207183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer.
    Wang Q; Yang ZL; Zou Q; Yuan Y; Li J; Liang L; Zeng G; Chen S
    Cancer Invest; 2016 Jul; 34(6):255-64. PubMed ID: 27389087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SHP2 is involved in the occurrence, development and prognosis of cancer.
    Li S; Qu J; Wang X; Zou Q; Li C
    Oncol Lett; 2023 Sep; 26(3):393. PubMed ID: 37600341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTP1B expression is an independent positive prognostic factor in human breast cancer.
    Soysal S; Obermann EC; Gao F; Oertli D; Gillanders WE; Viehl CT; Muenst S
    Breast Cancer Res Treat; 2013 Jan; 137(2):637-44. PubMed ID: 23242616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma.
    Hu Z; Fang H; Wang X; Chen D; Chen Z; Wang S
    Oncol Rep; 2014 Jul; 32(1):205-12. PubMed ID: 24858400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functions of Shp2 in cancer.
    Zhang J; Zhang F; Niu R
    J Cell Mol Med; 2015 Sep; 19(9):2075-83. PubMed ID: 26088100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tyrosine phosphatase SHP2 regulates focal adhesion kinase to promote EGF-induced lamellipodia persistence and cell migration.
    Hartman ZR; Schaller MD; Agazie YM
    Mol Cancer Res; 2013 Jun; 11(6):651-64. PubMed ID: 23512980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tyrosine phosphatase SHP2 gain-of-function mutation enhances malignancy of breast carcinoma.
    Hu Z; Wang X; Fang H; Liu Y; Chen D; Zhang Q; Liu X; Wei D; Qu C; Wang S
    Oncotarget; 2016 Feb; 7(5):5664-76. PubMed ID: 26673822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Src homology domain-containing phosphatase 2 suppresses cellular senescence in glioblastoma.
    Sturla LM; Zinn PO; Ng K; Nitta M; Kozono D; Chen CC; Kasper EM
    Br J Cancer; 2011 Oct; 105(8):1235-43. PubMed ID: 21934682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of SHP2 and related markers in non-small cell lung cancer: a tissue microarray study of 80 cases.
    Tang C; Luo D; Yang H; Wang Q; Zhang R; Liu G; Zhou X
    Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):386-94. PubMed ID: 23343958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into signalling networks regulating breast cancer stem cells.
    Swarbrick A; Daly RJ
    Breast Cancer Res; 2012 Sep; 14(5):321. PubMed ID: 22999218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shp2 signaling suppresses senescence in PyMT-induced mammary gland cancer in mice.
    Lan L; Holland JD; Qi J; Grosskopf S; Rademann J; Vogel R; Györffy B; Wulf-Goldenberg A; Birchmeier W
    EMBO J; 2015 Jun; 34(11):1493-508. PubMed ID: 25736378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in SHP2 whose function is different in vitro and in vivo.
    Kim MK; Park JY; Kang YN
    Pathol Res Pract; 2018 Jul; 214(7):1031-1039. PubMed ID: 29699904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase.
    Miura K; Wakayama Y; Tanino M; Orba Y; Sawa H; Hatakeyama M; Tanaka S; Sabe H; Mochizuki N
    Oncogene; 2013 Nov; 32(45):5292-301. PubMed ID: 23318428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3.
    Qi C; Han T; Tang H; Huang K; Min J; Li J; Ding X; Xu Z
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and its clinical significance of SHP2 in non-small cell lung cancer].
    Tang C; Zhou X; Yang H; Wang Q; Zhang R
    Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):98-101. PubMed ID: 20673499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.